Summary Pharmalink AB (Pharmalink) is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; and Busulipo which is under Phase II clinical trials. Its pipeline product also includes Xepol XP-28, which is used for the treatment of post-polio syndrome and is under pre-license sales. Pharmalink also partners with medical research institutions including the Karolinska Institute and Uppsala University. Pharmalink is headquartered in Stockholm, Sweden. Pharmalink AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack... Research Beam Model: Research Beam Product ID: 1996342 250 USD New
Pharmalink AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Pharmalink AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : August   2017
  • Pages : 25
  • Publisher : GlobalData
 
 
 
Summary

Pharmalink AB (Pharmalink) is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; and Busulipo which is under Phase II clinical trials. Its pipeline product also includes Xepol XP-28, which is used for the treatment of post-polio syndrome and is under pre-license sales. Pharmalink also partners with medical research institutions including the Karolinska Institute and Uppsala University. Pharmalink is headquartered in Stockholm, Sweden.

Pharmalink AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pharmalink AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pharmalink AB, Medical Devices Deals, 2011 to YTD 2017 9
Pharmalink AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pharmalink AB, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Pharmalink Acquires Anti-Inflammatory Drug from Synartro 11
Venture Financing 12
Pharmalink Raises USD12 Million in Financing 12
Pharmalink Raises US$15 Million In Series C Financing 13
Pharmalink Secures US$5.1 Million In Series B Financing 15
Partnerships 16
Archimedes Pharma Enters Into Licensing Agreement With Pharmalink 16
Equity Offering 17
Pharmalink Plans IPO 17
Pharmalink AB - Key Competitors 18
Pharmalink AB - Key Employees 19
Pharmalink AB - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Aug 15, 2017: Pharmalink strengthens its management team. Appoints new Chief Financial Officer and head of communications 21
May 18, 2017: Pharmalink announces appointment of new CEO 22
Jan 09, 2017: Pharmalink strengthens board with appointment of Maria Carell as Chair 23
Nov 30, 2016: Sweden’s Pharmalink obtains OMP designation for Nefecon 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Pharmalink AB, Pharmaceuticals & Healthcare, Key Facts 2
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pharmalink AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pharmalink AB, Deals By Therapy Area, 2011 to YTD 2017 8
Pharmalink AB, Medical Devices Deals, 2011 to YTD 2017 9
Pharmalink AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pharmalink Acquires Anti-Inflammatory Drug from Synartro 11
Pharmalink Raises USD12 Million in Financing 12
Pharmalink Raises US$15 Million In Series C Financing 13
Pharmalink Secures US$5.1 Million In Series B Financing 15
Archimedes Pharma Enters Into Licensing Agreement With Pharmalink 16
Pharmalink Plans IPO 17
Pharmalink AB, Key Competitors 18
Pharmalink AB, Key Employees 19
List of Figures
Pharmalink AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pharmalink AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pharmalink AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pharmalink AB, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter